What sort of follow-up services would Australian breast cancer survivors prefer if we could no longer offer long-term specialist-based care? A discrete choice experiment

Background:Early diagnosis and improved treatment outcomes have increased breast cancer survival rates that, in turn, have led to increased numbers of women undergoing follow-up after completion of primary treatment. The current workload growth is unsustainable for breast cancer specialists who also provide care for women newly diagnosed or with a recurrence. Appropriate and acceptable follow-up care is important; yet, currently we know little about patient preferences. The aim of this study was to explore the preferences of Australian breast cancer survivors for alternative modes of delivery of follow-up services.Methods:A self-administered questionnaire (online or paper) was developed. The questionnaire contained a discrete choice experiment (DCE) designed to explore patient preferences with respect to provider, location, frequency and method of delivery of routine follow-up care in years 3, 4 and 5 after diagnosis, as well as the perceived value of ‘drop-in’ clinics providing additional support. Participants were recruited throughout Australia over a 6-month period from May to October 2012. Preference scores and choice probabilities were used to rank the top 10 most preferred follow-up scenarios for respondents.Results:A total of 836 women participated in the study, of whom 722 (86.4%) completed the DCE. In the absence of specialist follow-up, the 10 most valued surveillance scenarios all included a Breast Physician as the provider of follow-up care. The most preferred scenario is a face-to-face local breast cancer follow-up clinic held every 6 months and led by a Breast Physician, where additional clinics focused on the side effects of treatment are also provided.Conclusion:Beyond the first 2 years from diagnosis, in the absence of a specialist led follow-up, women prefer to have their routine breast cancer follow-up by a Breast Physician (or a Breast Cancer Nurse) in a dedicated local breast cancer clinic, rather than with their local General Practitioner. Drop-in clinics for the management of treatment related side effects and to provide advice to both develop and maintain good health are also highly valued by breast cancer survivors.

[1]  J. Louviere,et al.  Conducting Discrete Choice Experiments to Inform Healthcare Decision Making , 2012, PharmacoEconomics.

[2]  T. Whelan,et al.  Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  Peter Orton.  Shared care , 1994, The Lancet.

[4]  Phyllis Butow,et al.  Survivorship care after breast cancer treatment--experiences and preferences of Australian women. , 2011, Breast.

[5]  M. Ryan,et al.  The veil of experience: do consumers prefer what they know best? , 2000, Health economics.

[6]  The optimal size of choice sets in choice experiments , 2006 .

[7]  C. Gotay,et al.  Assessment of Survivor Concerns (ASC): A newly proposed brief questionnaire , 2007, Health and quality of life outcomes.

[8]  P. Caputi,et al.  Investigating physical symptom burden and personal goal interference in early-stage breast cancer patients , 2014, Supportive Care in Cancer.

[9]  P. Butow,et al.  Follow up after breast cancer -- views of Australian women. , 2011, Australian family physician.

[10]  P. Ward,et al.  How do specialist breast nurses help breast cancer patients at follow-up? , 2010, Collegian.

[11]  Xingqiong Meng,et al.  Women with breast cancers' preferences for surveillance follow-up. , 2011, Collegian.

[12]  L. Holmberg,et al.  Nurse-led follow-up on demand or by a physician after breast cancer surgery: a randomised study. , 2004, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[13]  D. McFadden.  Conditional logit analysis of qualitative choice behavior , 1972 .

[14]  Mandy Ryan,et al.  Discrete choice experiments in health economics: a review of the literature. , 2012, Health economics.

[15]  Philippe Lambin,et al.  Follow-up after treatment for breast cancer: One strategy fits all? An investigation of patient preferences using a discrete choice experiment , 2010, Acta oncologica.

[16]  Mandy Ryan,et al.  Using discrete choice experiments to value health and health care , 2008 .

[17]  M. Jiwa,et al.  Will promoting general practitioners with special interests threaten access to primary care? , 2007, The Medical journal of Australia.

[18]  R. Speck,et al.  Prevalence of breast cancer treatment sequelae over 6 years of follow‐up , 2012, Cancer.

[19]  D. McFadden,et al.  MIXED MNL MODELS FOR DISCRETE RESPONSE , 2000 .

[20]  Malcolm Campbell,et al.  Comparing hospital and telephone follow-up after treatment for breast cancer: randomised equivalence trial , 2009, BMJ : British Medical Journal.

[21]  M. Ryan,et al.  Does One Size Fit All? Investigating Heterogeneity in Men’s Preferences for Benign Prostatic Hyperplasia Treatment Using Mixed Logit Analysis , 2009, Medical decision making : an international journal of the Society for Medical Decision Making.

[22]  K. Briffa,et al.  Cancer care coordinator: promoting multidisciplinary care--a pilot study in Australian general practice. , 2013, Collegian.

[23]  P. Lambin,et al.  Patient satisfaction with nurse-led telephone follow-up after curative treatment for breast cancer , 2010, BMC Cancer.

[24]  J. Dixon,et al.  Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors: the case for , 2008, Breast Cancer Research.

[25]  D. Cameron.  Extended follow-up of breast cancer patients in clinic wastes time for both patients and doctors: the case against , 2008, Breast Cancer Research.

[26]  Kym Spathonis,et al.  Follow-up care after breast cancer treatment: experiences and perceptions of service provision and provider interactions in rural Australian women , 2011, Supportive Care in Cancer.

[27]  G. Mann,et al.  Profile and Predictors of Long-term Morbidity in Breast Cancer Survivors , 2013, Annals of Surgical Oncology.

[28]  S. Davis,et al.  Intended follow up of women with breast cancer at low risk of recurrence and at least 5 years from diagnosis , 2014, Internal medicine journal.

[29]  A. Hole.  Fitting Mixed Logit Models by Using Maximum Simulated Likelihood , 2007 .

[30]  E. Winer,et al.  Breast cancer survivors' perceptions of survivorship care options. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.